S
Saradhi Mallampati
Assistant Professor
faculty
COM | Pathology Clinical
17 h-index
55 pubs
931 cited
Research Areas
Biography and Research Information
OverviewAI-generated summary
Saradhi Mallampati's research focuses on the application of genomic and transcriptomic analyses to understand and classify various human malignancies. His work involves utilizing advanced molecular techniques to identify chromosomal structural variants and genetic alterations critical for cancer diagnosis and monitoring. Mallampati has investigated the role of programmed cell death protein 1 (PD-1) blockade in combination with targeted therapies for hematologic and other cancers, aiming to enhance anti-tumor immunity. His publications also address the development and application of comprehensive gene panels for childhood malignancies and the comparative analysis of spatial transcriptomics profiling platforms for clinical evaluation. Mallampati's scholarship metrics include an h-index of 17, with 53 publications and 917 total citations.
Metrics
- h-index: 17
- Publications: 55
- Citations: 931
Selected Publications
-
82. Development and validation of a liquid biopsy next generation sequencing assay for HPV detection cancer patients (2025)
-
The Clinical Utility of a Next-Generation Sequencing-Based Approach to Detecting Circulating HPV DNA in Patients with Advanced Anal Cancer (2025)
-
SJPedPanel: A Pan-Cancer Gene Panel for Childhood Malignancies to Enhance Cancer Monitoring and Early Detection (2024)
Collaboration Network
Top Collaborators
Rajyalakshmi Luthra
The University of Texas MD Anderson Cancer Center (US)
8 shared publications
- Application of Optical Genome Mapping For Comprehensive Assessment of Chromosomal Structural Variants for Clinical Evaluation of Myelodysplastic Syndromes
- Incidental identification of inv(16)(p13.1q22)/<i>CBFB</i>–<i>MYH11</i> variant transcript in a patient with therapy-related acute myeloid leukemia by routine leukemia translocation panel screen: implications for diagnosis and therapy
- Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234
- High-Throughput Characterization of Cytogenomic Heterogeneity of MDS Using High-Resolution Optical Genome Mapping
- HPV integration as a prognostic biomarker for metastatic anal cancer: A next-generation sequencing ctDNA-based approach.
Showing 5 of 8 shared publications
Dzifa Y. Duose
The University of Texas MD Anderson Cancer Center (US)
5 shared publications
- Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
- Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234
- HPV integration as a prognostic biomarker for metastatic anal cancer: A next-generation sequencing ctDNA-based approach.
- The Clinical Utility of a Next-Generation Sequencing-Based Approach to Detecting Circulating HPV DNA in Patients with Advanced Anal Cancer
- 82. Development and validation of a liquid biopsy next generation sequencing assay for HPV detection cancer patients
Guillermo Garcia‐Manero
The University of Texas MD Anderson Cancer Center (US)
4 shared publications
- Application of Optical Genome Mapping For Comprehensive Assessment of Chromosomal Structural Variants for Clinical Evaluation of Myelodysplastic Syndromes
- Incidental identification of inv(16)(p13.1q22)/<i>CBFB</i>–<i>MYH11</i> variant transcript in a patient with therapy-related acute myeloid leukemia by routine leukemia translocation panel screen: implications for diagnosis and therapy
- High-Throughput Characterization of Cytogenomic Heterogeneity of MDS Using High-Resolution Optical Genome Mapping
- 11. Optical genome mapping for chromosomal structural variants analysis in hematological malignancies
Guillermo Montalban‐Bravo
The University of Texas MD Anderson Cancer Center (US)
4 shared publications
- Application of Optical Genome Mapping For Comprehensive Assessment of Chromosomal Structural Variants for Clinical Evaluation of Myelodysplastic Syndromes
- Incidental identification of inv(16)(p13.1q22)/<i>CBFB</i>–<i>MYH11</i> variant transcript in a patient with therapy-related acute myeloid leukemia by routine leukemia translocation panel screen: implications for diagnosis and therapy
- High-Throughput Characterization of Cytogenomic Heterogeneity of MDS Using High-Resolution Optical Genome Mapping
- 11. Optical genome mapping for chromosomal structural variants analysis in hematological malignancies
Rashmi Kanagal‐Shamanna
The University of Texas MD Anderson Cancer Center (US)
4 shared publications
- Application of Optical Genome Mapping For Comprehensive Assessment of Chromosomal Structural Variants for Clinical Evaluation of Myelodysplastic Syndromes
- Incidental identification of inv(16)(p13.1q22)/<i>CBFB</i>–<i>MYH11</i> variant transcript in a patient with therapy-related acute myeloid leukemia by routine leukemia translocation panel screen: implications for diagnosis and therapy
- High-Throughput Characterization of Cytogenomic Heterogeneity of MDS Using High-Resolution Optical Genome Mapping
- 11. Optical genome mapping for chromosomal structural variants analysis in hematological malignancies
Diana Rush
The University of Texas MD Anderson Cancer Center (US)
3 shared publications
- Application of Optical Genome Mapping For Comprehensive Assessment of Chromosomal Structural Variants for Clinical Evaluation of Myelodysplastic Syndromes
- High-Throughput Characterization of Cytogenomic Heterogeneity of MDS Using High-Resolution Optical Genome Mapping
- 11. Optical genome mapping for chromosomal structural variants analysis in hematological malignancies
L. Jeffrey Medeiros
The University of Texas MD Anderson Cancer Center (US)
3 shared publications
- Application of Optical Genome Mapping For Comprehensive Assessment of Chromosomal Structural Variants for Clinical Evaluation of Myelodysplastic Syndromes
- Incidental identification of inv(16)(p13.1q22)/<i>CBFB</i>–<i>MYH11</i> variant transcript in a patient with therapy-related acute myeloid leukemia by routine leukemia translocation panel screen: implications for diagnosis and therapy
- High-Throughput Characterization of Cytogenomic Heterogeneity of MDS Using High-Resolution Optical Genome Mapping
Ignacio I. Wistuba
The University of Texas MD Anderson Cancer Center (US)
3 shared publications
- Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234
- HPV integration as a prognostic biomarker for metastatic anal cancer: A next-generation sequencing ctDNA-based approach.
- The Clinical Utility of a Next-Generation Sequencing-Based Approach to Detecting Circulating HPV DNA in Patients with Advanced Anal Cancer
Pandurang Kolekar
St. Jude Children's Research Hospital (US)
3 shared publications
- SJPedPanel: A Pan-Cancer Gene Panel for Childhood Malignancies to Enhance Cancer Monitoring and Early Detection
- SJPedPanel: A pan-cancer gene panel for childhood malignancies
- Abstract 3898: SJPedPanel: A pan-cancer gene panel for childhood malignancies
Vidya Balagopal
St. Jude Children's Research Hospital (US)
3 shared publications
- SJPedPanel: A Pan-Cancer Gene Panel for Childhood Malignancies to Enhance Cancer Monitoring and Early Detection
- SJPedPanel: A pan-cancer gene panel for childhood malignancies
- Abstract 3898: SJPedPanel: A pan-cancer gene panel for childhood malignancies
Li Dong
St. Jude Children's Research Hospital (US)
3 shared publications
- SJPedPanel: A Pan-Cancer Gene Panel for Childhood Malignancies to Enhance Cancer Monitoring and Early Detection
- SJPedPanel: A pan-cancer gene panel for childhood malignancies
- Abstract 3898: SJPedPanel: A pan-cancer gene panel for childhood malignancies
Scott G. Foy
St. Jude Children's Research Hospital (US)
3 shared publications
- SJPedPanel: A Pan-Cancer Gene Panel for Childhood Malignancies to Enhance Cancer Monitoring and Early Detection
- SJPedPanel: A pan-cancer gene panel for childhood malignancies
- Abstract 3898: SJPedPanel: A pan-cancer gene panel for childhood malignancies
Heather L. Mulder
St. Jude Children's Research Hospital (US)
3 shared publications
- SJPedPanel: A Pan-Cancer Gene Panel for Childhood Malignancies to Enhance Cancer Monitoring and Early Detection
- SJPedPanel: A pan-cancer gene panel for childhood malignancies
- Abstract 3898: SJPedPanel: A pan-cancer gene panel for childhood malignancies
Emily M. Plyler
St. Jude Children's Research Hospital (US)
3 shared publications
- SJPedPanel: A Pan-Cancer Gene Panel for Childhood Malignancies to Enhance Cancer Monitoring and Early Detection
- SJPedPanel: A pan-cancer gene panel for childhood malignancies
- Abstract 3898: SJPedPanel: A pan-cancer gene panel for childhood malignancies
Zhikai Liang
St. Jude Children's Research Hospital (US)
3 shared publications
- SJPedPanel: A Pan-Cancer Gene Panel for Childhood Malignancies to Enhance Cancer Monitoring and Early Detection
- SJPedPanel: A pan-cancer gene panel for childhood malignancies
- Abstract 3898: SJPedPanel: A pan-cancer gene panel for childhood malignancies
Similar Researchers
Based on overlapping research topics
Madison P. Lee
University of Arkansas for Medical Sciences
Cancer Cells and Metastasis
Molecular Biology Techniques and Applications
Cancer Treatment and Pharmacology
David M. Parham
University of Arkansas for Medical Sciences
Cancer Genomics and Diagnostics
Cancer Cells and Metastasis
Molecular Biology Techniques and Applications
Ik Jae Shin
University of Arkansas for Medical Sciences
Cancer Genomics and Diagnostics
Cancer Cells and Metastasis
Molecular Biology Techniques and Applications
Sarah J. Nieman
Hendrix College
Cancer Cells and Metastasis
Molecular Biology Techniques and Applications
Cancer Treatment and Pharmacology
Peter D. Emanuel
University of Arkansas for Medical Sciences
Cancer Genomics and Diagnostics
Molecular Biology Techniques and Applications
Cancer Treatment and Pharmacology
Aaron Brice
University of Arkansas for Medical Sciences
Cancer Cells and Metastasis
Molecular Biology Techniques and Applications
Cancer Treatment and Pharmacology